2017
DOI: 10.1007/s10096-017-2941-8
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic resonance imaging study of cryptococcal neuroradiological lesions in HIV-negative cryptococcal meningitis

Abstract: Magnetic resonance (MR) scanning has become an important diagnostic and management tool in cryptococcal meningitis (CM). However, there are only isolated case reports documenting neuroradiological findings in human immunodeficiency virus (HIV)-negative patients with CM and none has clearly addressed the relationship between cerebral lesions on magnetic resonance imaging (MRI) and prognosis. The MR brain images available from 114 HIV-negative patients with CM were retrospectively analysed. Patients were divided… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
18
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 30 publications
3
18
1
Order By: Relevance
“…Assessing responsiveness to immunosuppressive agents including corticosteroids 6 creates a need for readily available clinical biomarkers of inflammation and neuronal damage that can be used in combination with microbiological biomarkers, such as early fungicidal activity 7 , 8 , to individualize and guide therapy. The imaging findings of CM have been described in HIV+ 9 15 , and HIV− patients 16 23 , including meningitis, meningoencephalitis, hydrocephalus, isolated cryptococcomas and disseminated cryptococcosis. Additional findings in HIV− subjects include choroid plexitis and ependymitis as well as pachymeningeal enhancement and ischemic infarcts 18 , 22 , 24 26 .…”
Section: Introductionmentioning
confidence: 99%
“…Assessing responsiveness to immunosuppressive agents including corticosteroids 6 creates a need for readily available clinical biomarkers of inflammation and neuronal damage that can be used in combination with microbiological biomarkers, such as early fungicidal activity 7 , 8 , to individualize and guide therapy. The imaging findings of CM have been described in HIV+ 9 15 , and HIV− patients 16 23 , including meningitis, meningoencephalitis, hydrocephalus, isolated cryptococcomas and disseminated cryptococcosis. Additional findings in HIV− subjects include choroid plexitis and ependymitis as well as pachymeningeal enhancement and ischemic infarcts 18 , 22 , 24 26 .…”
Section: Introductionmentioning
confidence: 99%
“…Previous reports examining neuroradiological findings in HIV-negative patients with CM refer little to WMLs (4-6); however, a recent study using diffusion tensor imaging has revealed marked white matter structural damage in HIV-negative patients with CM, which was associated with an increased CSF cryptococcal antigen titer (18). The prevalence of WMLs in HIV-negative patients with CM was more frequent than that previously reported despite the small number of patients included in our study.…”
Section: Discussionmentioning
confidence: 99%
“…In HIV-negative patients with CM, brain magnetic resonance imaging (MRI) often reveals dilated Virchow-Robin spaces, hydrocephalus, intracerebral nodules and pseudocysts, cortical and lacunar infarcts and gadolinium-enhanced leptomeningeal lesions (4-6). In addition, white matter lesions (WMLs) have been reported in a few patients (7,8); however, little is known about the pathogenic mechanisms of the lesions.…”
Section: Introductionmentioning
confidence: 99%
“…A previous report concerning the CT and MRI findings in 29 HIV patients with CM revealed cryptococcoma (mass lesions), dilated Virchow-Robin spaces (VRS), miliary enhancing nodules in the parenchyma and leptomeningeal-cisternal spaces, along with a mixed pattern ( 5 ). Another study in 114 non-HIV CM patients showed that initial MRI was most commonly characterized by radiological meningitis, followed by VRS dilation, hydrocephalus, masses, and pseudocysts/cryptococcomas ( 6 ). Bilateral hippocampal damage is uncommon in patients with CM.…”
Section: Discussionmentioning
confidence: 99%